I was recently prescribed oral Pilocarpine to help with my tear production, as I score a 2 in schirmers tests, and have been suffering since taking roaccutane 3 and a half years ago. However, there is no evidence that oral pilocarpine actually increases tear production. It seemed logical to me that Pilocarpine drops applied topically would have a much greater effect, and so I did some research. After sifting through pages of irrelevance, (it was all related to pilocarpine pills when I was searching for the effect of drops on dry eye) I finally found a study. The results are astonishing. I'll paste the most important part here:
"Result: Topical pilocarpine 0.05% significantly increased the tear production from a Schirmer’s I baseline of 4.09 mm ± 1.30 to 12.46 mm ± 9.02 after 2 months (p <0.01). Symptoms improved with noted decreased OSDI score from 33.72 ± 24.88 to 13.84 ± 8.98 (p = 0.01). There was no increase in pupil size."
That's right - it increases tear production from an average of 4mm to about 12 and a half. That's an improvement of more than 8mm. To put that in context, Cyclosporine increases tear production by an average of about 1mm at most, and usually even then takes about 6 months to take full effect. These patients met the criteria for severe dry eye with a 4mm schirmers score, but by the end of the study would be classified as being on the the lower end of the normal spectrum with tear production at 12mm. No current treatment comes even close to this. Why has this not been more widely publicised? Why is more research not being done on this? This seems on the face of it to be everything I and many of you have been searching for.
I have emailed several eye specialists whose care I am under, asking to be prescribed this immediately on a trial basis to see if it works. If/when this happens, I will keep you updated. In the mean time, I'd love to know your thoughts on this.
The study has been published here: http://paojournal.com/vol39no1/downloads/004.pdf
"Result: Topical pilocarpine 0.05% significantly increased the tear production from a Schirmer’s I baseline of 4.09 mm ± 1.30 to 12.46 mm ± 9.02 after 2 months (p <0.01). Symptoms improved with noted decreased OSDI score from 33.72 ± 24.88 to 13.84 ± 8.98 (p = 0.01). There was no increase in pupil size."
That's right - it increases tear production from an average of 4mm to about 12 and a half. That's an improvement of more than 8mm. To put that in context, Cyclosporine increases tear production by an average of about 1mm at most, and usually even then takes about 6 months to take full effect. These patients met the criteria for severe dry eye with a 4mm schirmers score, but by the end of the study would be classified as being on the the lower end of the normal spectrum with tear production at 12mm. No current treatment comes even close to this. Why has this not been more widely publicised? Why is more research not being done on this? This seems on the face of it to be everything I and many of you have been searching for.
I have emailed several eye specialists whose care I am under, asking to be prescribed this immediately on a trial basis to see if it works. If/when this happens, I will keep you updated. In the mean time, I'd love to know your thoughts on this.
The study has been published here: http://paojournal.com/vol39no1/downloads/004.pdf
Comment